Navigation Links
Lapatinib shows minimal effect against liver cancer
Date:9/8/2009

PHILADELPHIA Use of the molecularly targeted agent lapatinib to delay tumor growth and improve the survival of patients with inoperable hepatocellular carcinoma, or liver cancer, only benefited certain subgroups of patients. While results of this study were largely negative, patients that exhibited toxicity from the drug in the form of a skin rash appeared to have a greater tumor response and longer survival.

Findings of this phase II, multi-institutional study are published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

"These results may not be practice changing, but they do emphasize the need to continue developing strategies targeting epidermal growth factor receptor [EGFR] in hepatocellular carcinoma," said lead researcher Tanios Bekaii-Saab, M.D., assistant professor of medicine and pharmacology and medical director of gastrointestinal oncology at the Ohio State University Comprehensive Cancer Center.

The prevalence of hepatocellular carcinoma is increasing worldwide, and since this form of cancer typically responds poorly to chemotherapy, new treatments are necessary to help curb its rise. The current standard treatment for advanced hepatocellular carcinoma is sorafenib.

This study is one of the first trials to test the tolerability and efficacy of lapatinib in patients with advanced hepatocellular carcinoma. Lapatinib targets both EGFR and Human EGFR type 2 (HER2/neu) signaling pathways. The FDA approved this drug in March of 2007 for patients with breast cancer who were already using the chemotherapeutic agent capecitabine. Lapatinib works by inhibiting the tyrosine kinase activity associated with the two oncogenes EGFR and HER2/neu.

Twenty-six patients with advanced hepatocellular carcinoma received 1,500 mg/d of lapatinib by mouth for 28 days. Bekaii-Saab and colleagues evaluated tumor and blood specimens for expression of these signaling pathways. '/>"/>

Contact: Tara Yates
tara.yates@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer
2. GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. New research shows how chronic stress worsens neurodegenerative disease course
5. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
6. Circulating fats kill transplanted pancreas cells, study shows
7. New Heart Pump Shows Promise in Trial
8. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
9. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
10. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
11. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lapatinib shows minimal effect against liver cancer
(Date:3/31/2015)... April is Parkinson’s disease Awareness Month and the ... Days, 30 Ways to Make a Difference. Visit ... offer a new action each day throughout April to make ... this disease. , Every nine minutes there is ... 5,000 individuals in this country will learn they have Parkinson’s ...
(Date:3/31/2015)... March 31, 2015 Medical Technology Solutions ... Medical Practice Edition 2, allowing them to offer the ... with 24 physicians or less. Dragon Medical Practice Edition ... create quality patient records. , "MTSOA is constantly ... to our clients. Our goal has always been to ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 St. ... a growing network of leading healthcare systems, major physician ... patient information for the benefit of patients. The health ... record, that supports well coordinated care throughout the continuum ... has a long tradition of providing services to a ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 An individual’s ... most important ligaments in the leg providing stability, load ... their study at today’s Specialty Day meeting of the ... utilized MRI data to determine the potential for biologic ... currently understood about the healing of meniscus tears when ...
(Date:3/31/2015)... 2015 For bariatric health professionals who ... return on their investment, Rice Lake Weighing Systems ... Medicine 2015, April 8-12 at the Colorado Convention Center ... and medical offices, Rice Lake’s BCA uses the most ... Obesity Medicine 2015 delivers clinical and practical knowledge about ...
Breaking Medicine News(10 mins):Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 2Health News:Join The American Parkinson Disease Association to Commemorate April Parkinson's Awareness Month 3Health News:Medical Technology Solutions of America Announces Availability of Dragon® Medical Practice Edition 2 for Medical Professionals 2Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:New Way to Evaluate Meniscus Tear Outcomes 2Health News:Rice Lake Weighing Systems’ Body Composition Analyzer On Display at Obesity Medicine 2015 2
... 80 NHS Hospital Trusts on Sunday, thankfully no patient ... is in charge of the IT services in NHS ... Midlands were interrupted due to the failure of equipment ... log will be maintained till ,the system is restored. ...
... Canada seem to be on the high, which is a ... the spread of disease//. ,Ignorance is certainly not bliss, ... in Canada has reported an alarming figure of 58000 cases ... run a three times enhanced risk of HIV infection as ...
... the study conducted by Stephen Karpiak, a former research ... that many senior Americans above 50 years living with ... , This study was conducted in New York and1,000 ... Disease Control and Prevention statistics showed that more than ...
... health-care workers don protective clothing to stave-off infection ... diseases//, and bio-terrorism, they are still vulnerable ... Queen's University. ,"The strengths and ... considered when recommendations are made about which choice ...
... three years of age are underweight or malnourished in India, ... and Orissa.// ,Minister of State for Women and Child ... Rajya Sabha Monday that the national average of children below ... 1993 to 47 percent in 1999. ,Quoting the ...
... which is said to prevent about 75 percent of cervical ... women already exposed to the disease causing virus//, according to ... has been approved for women aged 9 to 26. However ... at the University of California-Irvine, argued that with more widespread ...
Cached Medicine News:Health News:Protective Clothing of Health Workers Insufficent Against Contamination 2Health News:Demand for More Widespread Use of HPV Vaccine 2Health News:Demand for More Widespread Use of HPV Vaccine 3
(Date:3/31/2015)... , March 31, 2015 ... 2015" therapeutic market research report of 68 pages ... online business intelligence library. The report ... on the therapeutic development for Pemphigus , ... assessment by drug target, mechanism of action (MoA), ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
(Date:3/31/2015)... , March 31, 2015  SynCardia Systems, Inc. has ... (IDE) clinical study on the effective use of its ... The FDA approval will ... as 30 heart failure patients. Patients enrolled in this ... as a bridge to a donor heart transplant. ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Elmed BC 50 M/M is an all purpose bipolar coagulator with a macro and micro mode. In the micro mode, the unit is ideally suitable for wet-field coagulation in ophthalmology, neurosurgery and other mi...
...
...
Medicine Products: